Skip to content



  1. A High-Speed DSL Play and a New Force in a $2 Billion Market October 18, 2007

    For the past month, supplement developer Nutrition 21 (NXXI:NASDAQ) has seemed incredibly weak. The share price sank, and even hit a 52-week low last week. But since Thursday, the stock has rallied back strong.

    Read more…


  2. Transition Pains Continue for Leading Brands October 11, 2007

    The beverage distributor turned natural juice company reported a net loss of 8 cents a share, compared with a profit of 2 cents a share in Q2 2006.

    Read more…


  3. Monogram Prepares for European Market Launch October 11, 2007

    CXS pick Monogram Biosciences (MGRM:NASDAQ) is busily preparing for its European debut. The company will provide Trofile, its proprietary testing services, for Pfizer's next generation HIV medication.

    Read more…


  4. October 2007 Issue October 1, 2007

    Get The Profit Potential of a Biotech Without the Hassle of FDA Approval

    Read more…